Abstract
Bernard–Soulier syndrome (BSS) is a rare autosomal recessive genetic disorder characterized by thrombocytopenia, circulating giant platelets, and prolonged bleeding time. BSS is explained by a defect in primary hemostasis owing to quantitative or qualitative defect in the GPIb–IX–V complex, composed of four subunits: GPIbα, GPIbβ, GPIX, and GPV. In this study, we report a novel GPIbβ defect in a Tunisian family, in which Serine 23 is substituted by a Stop codon causing a premature termination of translation. This defect was homozygous in the BSS patient and heterozygote in both the parents and sisters of the patient. We studied the effect of this mutation on the expression of the GPIb–IX complex by western blot, flow cytometry, and confocal microscopy: GPIbα and GPIX were absent on the surface of platelets, whereas they were present in the cytoplasm. These results led to conclude that the novel Ser 23 Stop mutation in GPIbβ is responsible of BSS in the studied family and hampers the complex to form on the platelets surface.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernard J, Soulier JP (1948) Sur une nouvelle variété de dystrophie thrombocytaire hémorragipare congénitale. Sem Hop Paris 24:3217
Alagille D, Josso F, Binet JL et al (1964) La dystrophie thrombocytaire hémorragipare: discussion nosologique. Nouv Rev Fr Hematol 4:755
Savage B, Sixma JJ, Ruggeri ZM (2002) Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci USA 99:425–430, doi:10.1073/pnas.012459599
Ware J (1998) Molecular analysis of the platelet glycoprotein Ib–IX–V receptor. Thromb Haemost 79:466–478
Li C, Martin SE, Roth GJ (1995) The genetic defect in two well-studied cases of Bernard–Soulier syndrome: a point mutation in the fifth leucine-rich repeat of platelet glycoprotein Ibα. Blood 86(10):3805–3814
Lanza F (2006) Bernard–Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet J Rare Dis 1:46, doi:10.1186/1750-1172-1-46
Hillmann A, Nurden A, Nurden P et al (2002) A novel hemizygous Bernard–Soulier Syndrome (BSS) mutation in the amino terminal domain of glycoprotein (GP)Ib-platelet characterization and transfection studies. Thromb Haemost 88:1026–1032
Kenny D, Morateck PA, Gill JC et al (1999) The critical interaction of glycoprotein (GP)Ib beta with GPIX—a genetic cause of Bernard–Soulier syndrome. Blood 93:2968–2975
Lopez JA, Weisman S, Sanan DA et al (1994) Glycoprotein (GP) Ibß is the critical subunit linking GPIbα and GPIX in the GPIb-complex. J Biol Chem 269:23716–23721
Perrault C, Moog S, Rubinstein E et al (2001) A novel monoclonal antibody against the extracellular domain of GPIb beta modulates vWF mediated platelet adhesion. Thromb Haemost 86(5):1238–1248
Strassel C, David T, Eckly A et al (2006) Synthesis of GPIbß with novel transmembrane and cytoplasmic sequences in a Bernard–Soulier patient resulting in GPIb-defective signalling in CHO cells. J Thromb Haemost 4:217–228 doi:10.1111/j.1538-7836.2005.01654.x
Afshar-Kharghan V, Craig FE, Lopez JA (2000) Bernard–Soulier syndrome in a patient doubly heterozygous for two frameshift mutations in the glycoprotein Ibα gene. Br J Haematol 110:919–924, doi:10.1046/j.1365-2141.2000.02261.x
Moran N, Morateck PA, Deering A et al (2000) Surface expression of glycoprotein Ibα is dependent on glycoprotein Ibß: evidence from a novel mutation causing Bernard–Soulier syndrome. Blood 96(2):532–539
Hillmann A, Nurden A, Nurden P et al (2002) A novel hemizygous Bernard–Soulier Syndrome (BSS) mutation in the amino terminal domain of glycoprotein (GP)Ibbeta-platelet characterization and transfection studies. Thromb Haemost 88(6):1026–1032
Sac-Tung G, Dong J, Lopez JA (1996) Biosynthetic defect in platelet glycoprotein IX mutants associated with Bernad–Soulier syndrome. Blood 87:1361–1367
Bodnar RJ, Xi X, Li Z et al (2002) Regulation of glycoprotein Ib-IX-Von Willebrand factor interaction by c-AMP-dependent protein kinase-mediated phosphorylation at Ser166 of Glycoprotein Ibß. J Biol Chem 277(49):47080–47087, doi:10.1074/jbc.M208329200
Kunishima S, Lopez JA, Kobayashi S et al (1997) Missense mutations of the glycoprotein (GP) Ib beta gene impairing the GPIb alpha/beta disulfide linkage in a family with giant platelet disorder. Blood 89:2404–2412
Kunishima S, Tomiyama Y, Honda S et al (1999) Cys97Tyr mutation in the glycoprotein IX gene associated with Bernard–Soulier syndrome. Br J Haematol 107:539–545, doi:10.1046/j.1365-2141.1999.01733.x
Lopez JA, Chung DW, Fujikawa K et al (1988) The α and β chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 85:2135–2139, doi:10.1073/pnas.85.7.2135
Acknowledgements
This work is dedicated to the memory of our colleague Amira Romdhani. Imène Ayadi is thanked for initiating the work and for discussion. This work was supported by a Tunisian grant contract (Contrat Programme CBS-MESRT 02-06).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hadjkacem, B., Elleuch, H., Gargouri, J. et al. Bernard–Soulier syndrome: novel nonsense mutation in GPIbβ gene affecting GPIb–IX complex expression. Ann Hematol 88, 465–472 (2009). https://doi.org/10.1007/s00277-008-0611-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0611-8